Evidence map›Paper›PMID 41443252›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2026

SPARC: a structural pathogenicity algorithm for risk classification of hERG variants.

Frank C Chatelain, Barbara Ribeiro de Oliveira, Guillaume Grataloup, Noé Robert, Malak Alameh, Aurélie Thollet, Jérôme Montnach, Sylvain Feliciangeli, Aline Rio, Floriane Bibault and 10 more

Abstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Frank C ChatelainUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0000-0002-8426-8893
Barbara Ribeiro de OliveiraLabEx « Ion Channels, Science and Therapeutics », Université Côte d'Azur, Valbonne, France.ORCID 0000-0002-2269-5750
Guillaume GrataloupUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0009-0004-9617-4431
Noé RobertUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0009-0005-7442-0774
Malak AlamehLabEx « Ion Channels, Science and Therapeutics », Université Côte d'Azur, Valbonne, France.
Aurélie TholletCHU Nantes, l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0002-3776-6072
Jérôme MontnachLabEx « Ion Channels, Science and Therapeutics », Université Côte d'Azur, Valbonne, France.ORCID 0000-0001-5100-5571
Sylvain FeliciangeliUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.
Aline RioNantes Université, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.
Floriane BibaultNantes Université, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.ORCID 0009-0001-8212-0908
Delphine BichetUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0000-0002-9601-089X
Olivier BignucoloUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0000-0003-4735-049X
Fabrice ExtramianaDépartement de Rythmologie, Centre de Référence Maladies Cardiaques Héréditaires, Filière Cardiogen, Paris, France.ORCID 0000-0001-8123-4842
Rupamanjari MajumderNantes Université, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.ORCID 0000-0002-3851-9225
Jean-Jacques SchottNantes Université, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.ORCID 0000-0002-9578-9475
Vincent ProbstCHU Nantes, l'institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France.ORCID 0000-0002-5492-8619
Isabelle DenjoyDépartement de Rythmologie, Centre de Référence Maladies Cardiaques Héréditaires, Filière Cardiogen, Paris, France.ORCID 0000-0002-1786-9461
Florian LesageUniversité Côte d'Azur, INSERM, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire, Valbonne, France.ORCID 0000-0002-4406-7106
Gildas LoussouarnLabEx « Ion Channels, Science and Therapeutics », Université Côte d'Azur, Valbonne, France.ORCID 0000-0001-8007-5931
Michel De WaardNantes Université, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.ORCID 0000-0002-2782-9615

Funding

Agence Nationale de la Recherche ANR-11-LABX-0015Agence Nationale de la Recherche ANR-21-CE17-0010-01European FEDER 2017/FEDER/PL0014592Fédération Française de CardiologieFondation LeducqRégion Pays de la Loire 2016-11092/11093
6 · The paper itself

Abstract

Inherited mutations in the KCNH2 gene, which encodes the cardiac hERG potassium channel, are major contributors to arrhythmogenic syndromes such as long QT and short QT syndromes. However, clinical interpretation of the growing number of missense variants - many of which are classified as variants of uncertain significance (VUS) - remains a pressing challenge. Here, we present a semi-automated in silico pipeline for predicting hERG variant pathogenicity, acting as a binary classifier and integrating five structural metrics - residue volume, hydrophobicity, charge, steric clashes, and proximity to pathogenic hotspots - into a composite structural pathogenicity score (SPS) scaled from 1 to 5. Applied to 1727 hERG variants from ClinVar and from a French nationwide cohort, this binary classifier, termed SPARC, identified 260 variants as high risk of pathogenicity with SPS ≥3.25, of which a representative subset from the French cohort was functionally validated using high-throughput automated patch-clamp. Functional phenotyping confirmed the structural predictions, including for several VUS, demonstrating that comprehensive structural scoring can reliably stratify variant pathogenicity. This approach, benchmarked with Alpha Missense and Revel, offers a superior scalable, cost-effective pre-screening tool to guide clinical variant interpretation and prioritization for experimental validation.

Indexed as

AlgorithmsArrhythmias, CardiacERG1 Potassium ChannelLong QT SyndromeMutation, MissenseAction PotentialsComputer SimulationFranceGenetic Predisposition to DiseaseHumansPhenotypePredictive Value of TestsReproducibility of ResultsRisk AssessmentRisk FactorsStructure-Activity RelationshipERG1 Potassium ChannelKCNH2 protein, humanArrhythmiahERG channelHigh throughput phenotypingStructural pathogenicity scoreUCSF ChimeraVariant of uncertain significance

Identifiers

PMID41443252
PMCPMC12877647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.